Buprenorphine

Buprenorphine is an opioid partial agonist that is effective for many in the treatment of opioid use disorder (OUD). Similarly to methadone, buprenorphine is a controlled substance and has the potential for misuse and diversion. However, unlike methadone, it is less likely to lead to overdose unless combined with other sedatives.

Related Training Resources

SAMHSA: Learn about the federal statutes, regulations, and guidelines that apply to medications for practitioners and opioid treatment programs (OTPs).
Credit Available:
CE Credit(s): No
Certificate: No
Buprenorphine Prescription Log (to be kept in physician master file or buprenorphine-treated patients)
Credit Available:
CE Credit(s): No
Certificate: No
Drug Accountability Record (for Stock Buprenorphine Supplies)
Credit Available:
CE Credit(s): No
Certificate: No
Patient Information and Consent To Treatment With Buprenorphine/Naloxone
Credit Available:
CE Credit(s): No
Certificate: No
Consent for Treatment with Buprenorphine/Naloxone
Credit Available:
CE Credit(s): No
Certificate: No
Agreement for Treatment with Buprenorphine/Naloxone
Credit Available:
CE Credit(s): No
Certificate: No
Buprenorphine/Naloxone Treatment Agreement
Credit Available:
CE Credit(s): No
Certificate: No
Buprenorphine Treatment Intake History and Physical
Credit Available:
CE Credit(s): No
Certificate: No
Buprenorphine Checklist: Initial Patient Contact (for use by treatment program personnel who answer inquiries about buprenorphine treatment)
Credit Available:
CE Credit(s): No
Certificate: No
Buprenorphine/Naloxone Maintenance Treatment Intake Questionnaire for Patient Treatment-Planning Questions
Loading more
2018 Steering Committee Meeting

Buprenorphine Training

PCSS-MOUD offers free buprenorphine training to learn about prescribing medication for the treatment of opioid use disorder.

Buprenorphine Quick Start Guide​

SAMHSA has developed a Buprenorphine Quick Start Guide for practitioners looking to prescribe buprenorphine.